A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression

Oncology Reports

Volumn 25, Issue 3, 2011, Pages 685-691

  Sun, Jinxia ^a   Lei, Zhe ^a   Liu, Reng Yun ^a   Lu, Yufeng ^b   Zhuang, Zhixiang ^b   Jiang, Xiefang ^a   Qian, Qian ^a   Liu, Zeyi ^a   Zhao, Jun ^a,b   Zhang, Hong Tao ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Allelic specific expression; Haplotype; Non small cell lung cancer; TGFBR1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA FLANKING REGION; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 79551608625     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1135     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Liu Z, Li W, Lei Z, Zhao J, Chen XF, Liu R, Peng X, Wu ZH, Chen J, Liu H, Zhou QH and Zhang HT: CpG island methylator phenotype involving chromosome 3p confers an increased risk of non-small cell lung cancer. J Thorac Oncol 5: 790-797, 2010.
3. Alberg AJ, Brock MV and Samet JM: Epidemiology of lung cancer: looking to the future. J Clin Oncol 23: 3175-3185, 2005.
4. Heldin CH, Miyazono K and ten Dijke P: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
5. Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A and Reiss M: Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 82: 43-51, 1999.
6. Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y and Takenoshita S: Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res 60: 4507-4512, 2000.
7. Im YH, Kim HT, Kim IY, Factor VM, Hahm KB, Anzano M, Jang JJ, Flanders K, Haines DC, Thorgeirsson SS, Sizeland A and Kim SJ: Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res 61: 6665-6668, 2001.
8. Park C, Kim WS, Choi Y, Kim H and Park K: Effects of transforming growth factor beta (TGF-beta) receptor on lung carcinogenesis. Lung Cancer 38: 143-147, 2002.
9. Zhang HT, Fei QY, Chen F, Qi QY, Zou W, Wang JC, Zhang RM, Tao SH, Chen XF and Luo ZW: Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer. Lung Cancer 40: 281-287, 2003.
10. Chen T, Triplett J, Dehner B, Hurst B, Colligan B, Pemberton J, Graff JR and Carter JH: Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 61: 4679-4682, 2001.
11. Chen T, Yan W, Wells RG, Rimm DL, McNiff J, Leffell D and Reiss M: Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases. Int J Cancer 93: 653-661, 2001.
12. Zeng Q, Phukan S, Xu Y, Sadim M, Rosman DS, Pennison M, Liao J, Yang GY, Huang CC, Valle L, Di Cristofano A, de la Chapelle A and Pasche B: TGFBR1 haploinsufficiency is a potent modifier of colorectal cancer development. Cancer Res 69: 678-686, 2009.
13. Zhang HT, Zhao J, Zheng SY and Chen XF: Is TGFBR1*6A really associated with increased risk of cancer? J Clin Oncol 23: 7743-7744; author reply 7744-7746, 2005.
14. Zhang HT: Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies. Lung Cancer 49: 419-420, 2005.
15. Liao RY, Mao C, Qiu LX, Ding H, Chen Q and Pan HF: TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls. Mol Biol Rep 37: 3227-3232, 2010.
16. You W, Liu Z, Zhao J, Zheng M, Zheng SY, Liu X and Zhang HT: No association between TGFBR1*6A and lung cancer. J Thorac Oncol 2: 657-659, 2007.
17. Zhao J, Liu Z, Li W, Liu X, Chen XF and Zhang HT: Infrequently methylated event at sites -362 to -142 in the promoter of TGF beta R1 gene in non-small cell lung cancer. J Cancer Res Clin Oncol 134: 919-925, 2008.
18. Lei Z, Liu RY, Zhao J, Liu Z, Jiang X, You W, Chen XF, Liu X, Zhang K, Pasche B and Zhang HT: TGFBR1 haplotypes and risk of non-small cell lung cancer. Cancer Res 69: 7046-7052, 2009.
19. Valle L, Serena-Acedo T, Liyanarachchi S, Hampel H, Comeras I, Li Z, Zeng Q, Zhang HT, Pennison MJ, Sadim M, Pasche B, Tanner SM and de la Chapelle A: Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer. Science 321: 1361-1365, 2008.
20. Pasche B, Wisinski KB, Sadim M, Kaklamani V, Pennison MJ, Zeng Q, Bellam N, Zimmerman J, Yi N, Zhang K, Baron J, Stram DO and Hayes MG: Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs. J Exp Clin Cancer Res 29: 57, 2010.
21. Pinheiro H, Bordeira-Carrico R, Seixas S, Carvalho J, Senz J, Oliveira P, Inacio P, Gusmao L, Rocha J, Huntsman D, Seruca R and Oliveira C: Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 19: 943-952, 2010.
22. Carvajal-Carmona LG, Churchman M, Bonilla C, Walther A, Lefevre JH, Kerr D, Dunlop M, Houlston R, Bodmer WF and Tomlinson I: Comprehensive assessment of variation at the transforming growth factor {beta} type 1 receptor locus and colorectal cancer predisposition. Proc Natl Acad Sci USA 107: 7858-7862, 2010.
23. Guda K, Natale L, Lutterbaugh J, Wiesner GL, Lewis S, Tanner SM, Tomsic J, Valle L, de la Chapelle A, Elston RC, Willis J and Markowitz SD: Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients. Cancer Res 69: 4959-4961, 2009.
24. Barrett JC, Fry B, Maller J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005.
25. Zhang HT, Chen XF, Wang MH, Wang JC, Qi QY, Zhang RM, Xu WQ, Fei QY, Wang F, Cheng QQ, Chen F, Zhu CS, Tao SH and Luo Z: Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin Cancer Res 10: 2359-2367, 2004.
26. Vellucci VF and Reiss M: Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene. Genomics 46: 278-283, 1997.
27. Pasche B, Knobloch TJ, Bian Y, Liu J, Phukan S, Rosman D, Kaklamani V, Baddi L, Siddiqui FS, Frankel W, Prior TW, Schuller DE, Agrawal A, Lang J, Dolan ME, Vokes EE, Lane WS, Huang CC, Caldes T, Di Cristofano A, Hampel H, Nilsson I, von Heijne G, Fodde R, Murty VV, de la Chapelle A and Weghorst CM: Somatic acquisition and signaling of TGFBR1*6A in cancer. JAMA 294: 1634-1646, 2005.
28. Milani L, Lundmark A, Nordlund J, Kiialainen A, Flaegstad T, Jonmundsson G, Kanerva J, Schmiegelow K, Gunderson KL, Lonnerholm G and Syvanen AC: Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation. Genome Res 19: 1-11, 2009.